CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse® technology in patients with s...
Enregistré dans:
Auteurs principaux: | Garcia-Valdecasas Gayo Sonsoles, Ruiz-Alvarez Maria Jesus, Gonzalez-Gay Daniel, Ramos-Corral Raquel, Marquez-Lietor Eva, Del Amo Nazaret, Plata Maria del Carmen, Guillén-Santos Raquel, Arribas Ignacio, Cava-Valenciano Fernando |
---|---|
Format: | article |
Langue: | EN ES |
Publié: |
De Gruyter
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/982c08d81cda467fa39bf2018dbdc8d1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
El CYFRA 21-1 en pacientes con sospecha de cáncer: evaluación de un punto de corte óptimo para evaluar la eficacia diagnóstica y el valor pronóstico
par: Garcia-Valdecasas Gayo Sonsoles, et autres
Publié: (2020) -
A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study
par: Narongchai Autsavapromporn, et autres
Publié: (2021) -
Role of afatinib in the treatment of advanced lung squamous cell carcinoma
par: Vavalà T
Publié: (2017) - Current medical literature.
- Lung cancer international